An Eli Lilly subsidiary has halted deliveries of its insulin product mainly used by children The supply of Humalog-brand insulin made by Eli Lilly has practically run out in Russia, the newspaper Kommersant has reported. Most of the drug’s customers have been children with type-1 diabetes.